Hormone Health8 min read

Is Hormone Therapy Safe? What the Research Actually Says

For more than 20 years, one study shaped how women — and even many healthcare providers — thought about hormone therapy. The problem? Most people only remember the headlines.

Written by Mallory Jones, MSN, APRN, FNP-C, CWHSPublished July 9, 2026Last medically reviewed July 9, 2026
A healthcare provider and a woman in her early fifties reviewing treatment options together during a relaxed office consultation
Key takeaways
  • 01Much of the fear surrounding hormone therapy comes from a 2002 study that has since been better understood.
  • 02For healthy women younger than 60, or within 10 years of menopause, hormone therapy often has a favorable benefit-risk profile.
  • 03The type of hormone and how it's delivered matter. Oral estrogen and transdermal estrogen don't carry the same risks.
  • 04Hormone therapy isn't one-size-fits-all. The best treatment depends on your symptoms, medical history, goals, and preferences.
  • 05The decision to start — or continue — hormone therapy should be individualized and revisited over time.

"I thought hormones were dangerous."

If I had a dollar for every time someone asked me this, I could probably retire.

Seriously though, it's one of the most common questions I hear.

Many women come into their appointment convinced hormone therapy causes breast cancer, heart attacks, or strokes because that's what they've heard for years — from friends, family members, social media, or even healthcare providers.

The truth is much more complicated.

Most of those fears can be traced back to a single study published in 2002. While that study was incredibly important, it doesn't tell the whole story, and we've learned a tremendous amount since then.


The study everyone remembers — but few people know

In 2002, the Women's Health Initiative (WHI) made national headlines when researchers stopped one arm of their hormone therapy study early after identifying increased risks with a specific hormone regimen.

The headlines were alarming. Women stopped taking hormone therapy overnight. Prescriptions dropped dramatically. Many clinicians stopped prescribing it altogether.

But here's what often gets left out of the conversation.

The average woman in that study was 63 years old. Many participants were more than 10 years past menopause and already had underlying cardiovascular disease.

That's very different from the typical patient sitting in my virtual office — a healthy woman in her late 40s or early 50s who has recently entered menopause and is struggling with hot flashes, poor sleep, mood changes, or vaginal dryness.

The study also looked at oral conjugated equine estrogen and medroxyprogesterone acetate, not the estradiol and micronized progesterone that are commonly prescribed today.

Another important finding rarely made the headlines: women who had undergone a hysterectomy and received estrogen alone did not demonstrate the same increase in breast cancer risk.

Today we know that timing, patient selection, and the specific medications being used all matter.


What the research shows today

Current evidence supports hormone therapy as the most effective treatment for moderate to severe menopausal symptoms.

For appropriately selected women, hormone therapy can improve:

  • Hot flashes
  • Night sweats
  • Sleep quality
  • Vaginal dryness
  • Pain with intercourse
  • Urinary symptoms related to menopause
  • Overall quality of life

It also helps preserve bone density and reduces the risk of osteoporosis-related fractures.

For many women, these improvements aren't just nice to have — they're life changing.


Not all estrogen is the same

One thing that surprises many patients is that the route of administration matters.

Oral estrogen travels through the liver before entering the bloodstream. That first-pass metabolism increases certain clotting factors and is associated with a higher risk of blood clots.

Transdermal estrogen — including patches, gels, sprays, and some creams — is absorbed through the skin and largely bypasses the liver.

Because of that, transdermal estrogen does not appear to carry the same increased risk of blood clots seen with oral estrogen.

That's one reason I often recommend transdermal estrogen, especially for women who have migraine with aura, elevated BMI, or other cardiovascular risk factors.


Let's talk about breast cancer

Breast cancer is understandably one of the biggest concerns women have. It's also one of the most misunderstood topics in hormone therapy.

Current research shows that women using combined estrogen and progesterone therapy have a small increase in breast cancer risk with longer durations of treatment.

The key word is small.

Every medication has risks, and hormone therapy is no exception. The important part is putting those risks into perspective and discussing them honestly.

Women who have had a hysterectomy and use estrogen alone did not demonstrate the same increase in breast cancer risk in the Women's Health Initiative.

This is why your personal history, family history, and overall health matter so much when deciding whether hormone therapy is appropriate.


Hormone therapy should be individualized

One thing I tell patients all the time is that there isn't one "best" hormone therapy. Every woman is different.

Some women do great with FDA-approved medications. Others benefit from compounded medications when they're clinically appropriate.

For example, there isn't currently an FDA-approved testosterone product specifically designed for women in the United States. When testosterone is appropriate — such as for carefully selected women with hypoactive sexual desire disorder (HSDD) — compounded therapy is often the most practical option.

Depending on the patient, I may recommend a compounded cream or an injectable medication. One isn't automatically better than the other.

Some women are very consistent with applying a cream every day and get excellent results. Others don't absorb topical medications as well, don't love a daily routine, or simply achieve better symptom control with injections.

My goal isn't to fit everyone into the same treatment plan. My goal is to find the option that works best for your body, your lifestyle, and your goals.


When hormone therapy isn't the right choice

Hormone therapy is safe for many women, but it isn't appropriate for everyone.

Systemic hormone therapy may not be recommended for women with:

  • Active breast cancer, unless managed with their oncology team
  • Estrogen-dependent cancers
  • Unexplained vaginal bleeding, until it has been evaluated
  • Active or recent blood clots
  • Recent stroke or heart attack
  • Active liver disease

It's also important to remember that vaginal estrogen is different from systemic hormone therapy. Very little is absorbed into the bloodstream, which is why it has a different safety profile and is an excellent treatment for many women experiencing vaginal dryness, painful intercourse, or recurrent urinary tract infections related to menopause.


How I approach these conversations

Every consultation starts with listening.

I want to know:

  • What symptoms are bothering you the most?
  • How are they affecting your daily life?
  • Where are you in the menopause transition?
  • Do you still have your uterus?
  • What does your personal and family medical history look like?
  • What are your goals?

Then we review the risks and benefits together. We choose the medication, route, and dose that make the most sense for you.

Hormone therapy isn't about finding a perfect protocol on day one. It's common to make adjustments over the first few months as we see how your body responds. That's normal.


The bottom line

Hormone therapy isn't right for every woman.

But it's also not the dangerous treatment many people were led to believe after the headlines of 2002.

For the right patient, started at the right time and monitored appropriately, hormone therapy remains one of the most effective treatments we have for managing menopausal symptoms and improving quality of life.

My job isn't to convince you to take hormones. My job is to give you accurate, evidence-based information, answer your questions honestly, and help you decide what makes the most sense for your health and your goals.

Because every woman deserves a treatment plan that's individualized — not one based on fear, outdated headlines, or social media myths.

References

  • Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women (Women's Health Initiative). JAMA. 2002;288(3):321-333.
  • Manson JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: WHI randomized trials. JAMA. 2017;318(10):927-938.
  • Vinogradova Y, et al. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies. BMJ. 2019;364:k4810.
  • Chlebowski RT, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the WHI trials. JAMA. 2020;324(4):369-380.
  • Hodis HN, Mack WJ. Menopausal hormone replacement therapy and reduction of all-cause mortality: the timing hypothesis. Am J Med. 2021.
  • The Menopause Society. The 2025 Hormone Therapy Position Statement of The Menopause Society. Menopause. 2025.
  • American College of Obstetricians and Gynecologists. Practice Bulletin: Management of Menopausal Symptoms (reaffirmed 2024).

Related care

If this is what you're working through, read more about Menopause & Perimenopause Hormone Therapy.

Ready for the conversation?

Have a real visit with Mallory.

Telehealth visits with one clinician, continuity between visits, and no rotating staff.